RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Remimazolam besylate, as a new benzodiazepine drug, has few advantages in respiratory
depression and gastrointestinal motility. The study will further explore the safety and
effectiveness of remimazolam besylate n the sedation of mechanically ventilated patients
after oral and maxillofacial surgery in the ICU